| 171 |
Assessment of cognitive functions and psychiatric symptoms in hepatitis C patients receiving pegylated interferon alpha and ribavirin: A prospective cohort study |
2019 |
| 172 |
Cerebellar Inhibition in Hepatic Encephalopathy |
2019 |
| 173 |
Cerebellar Inhibition in Hepatic Encephalopathy |
2019 |
| 174 |
Changes in recruitment of motor cortex excitation and inhibition in patients with drug-induced tardive syndromes.
|
2019 |
| 175 |
Changes in Vital Signs During Epileptic and Psychogenic Nonepileptic Attacks: A Video-EEG Study. |
2019 |
| 176 |
Cognitive and psychological evaluation of a sample of Egyptian patients with Behcet's disease without neurological manifestations |
2019 |
| 177 |
Genetic and phenotypic characterization of NKX6-2-related spastic ataxia and hypomyelination |
2019 |
| 178 |
PDXK mutations cause polyneuropathy responsive to pyridoxal 5′‐phosphate supplementation |
2019 |
| 179 |
Prognostic Value of “A” Waves in Patients With Guillain
Barre Syndrome |
2019 |
| 180 |
Repetitive transcranial magnetic stimulation for treatment of tardive syndromes: double randomized clinical trial. |
2019 |
هل لديك سؤال ؟
